Miguel Ángel
Hernández Pérez
Part Time Assistant Professor (Health Science)
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublications in collaboration with researchers from Icahn School of Medicine at Mount Sinai (1)
2018
-
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415